Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Aug 12 · below the Ichimoku cloud · RSI 17 (oversold) · MACD below its signal · at its 52-week low
None of the 29 investors followed here reported a position in UAMY in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a UAMY trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 31, 2026 | Carrabba Joseph ADirector | Purchase at price 4.72 per share. | 21.3K | $100.54K |
| Aug 31, 2026 | Bardswich Lloyd JosephOfficer and Director | Purchase at price 4.64 per share. | 20K | $92.70K |
| Aug 30, 2026 | Aguirre Blaise A. M.D.Director | Purchase at price 5.04 per share. | 1.4K | $7.05K |
| Aug 27, 2026 | Evans Gary COfficer and Director | Purchase at price 4.92 per share. | 20K | $98.40K |
| Jun 14, 2026 | Marinelli Jon R.Director | Purchase at price 7.45 per share. | 12.5K | $93.13K |
| Jan 14, 2026 | Mcmanus Michael A JrDirector | Stock Award(Grant) at price 0.00 per share. | 6.6K | — |
| Jan 14, 2026 | Carrabba Joseph ADirector | Stock Award(Grant) at price 0.00 per share. | 6.6K | — |
| Jan 14, 2026 | Aguirre Blaise A. M.D.Director | Stock Award(Grant) at price 0.00 per share. | 6.6K | — |
| Sep 25, 2025 | Evans Gary CChief Executive Officer | Purchase at price 6.13 per share. | 100K | $613.20K |
| May 26, 2025 | Mcmanus Michael A JrDirector | Stock Award(Grant) at price 0.00 per share. | 22.7K | — |
| May 26, 2025 | Carrabba Joseph ADirector | Stock Award(Grant) at price 0.00 per share. | 22.7K | — |
| May 26, 2025 | Aguirre Blaise A. M.D.Director | Stock Award(Grant) at price 0.00 per share. | 22.7K | — |
| Dec 9, 2024 | Mcmanus Michael A JrDirector | Purchase at price 1.46 per share. | 70K | $102.06K |
| Dec 9, 2024 | Evans Gary CChief Executive Officer | Purchase at price 1.45 per share. | 200K | $289.40K |
| Nov 17, 2024 | Mcmanus Michael A JrDirector | Purchase at price 0.56 per share. | 50K | $28.25K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 46.0 | 22.0 | -2.3 | 37.6 | -25.2 | -19.2 | -30.2 | -3.9 | -14.4 | -34.9 | −45.9% | ||
| 2025 | -2.8 | -19.8 | 59.4 | 45.9 | -24.6 | -9.9 | 40.4 | 48.7 | 36.3 | 30.2 | -24.3 | -17.8 | +183.6% |
| 2024 | -8.0 | -8.7 | 19.0 | -12.0 | 63.6 | -5.6 | 8.8 | 81.1 | 13.4 | -18.4 | 22.6 | 132.9 | +608.0% |
| 2023 | -18.4 | 0.0 | -5.0 | -5.3 | -11.1 | -3.1 | 38.7 | 0.0 | -14.0 | -8.1 | -23.5 | -3.8 | −49.0% |
| 2022 | -10.0 | 8.9 | 32.7 | -40.0 | 2.6 | 0.0 | 15.0 | -4.3 | -15.9 | 2.7 | -5.3 | 36.1 | −2.0% |
| 2021 | 59.6 | 72.3 | -15.4 | -22.3 | -9.6 | 16.5 | -2.0 | -3.1 | -3.2 | -3.3 | -28.4 | -20.6 | −3.8% |
| 2020 | 5.1 | 0.0 | -19.5 | 9.1 | -8.3 | 48.5 | -18.4 | 25.0 | -42.0 | 31.0 | 7.9 | 26.8 | +33.3% |
| 2019 | 15.5 | -20.9 | -11.3 | 12.8 | 7.5 | -1.8 | 30.4 | -8.2 | -16.4 | -10.7 | -18.0 | -4.9 | −32.8% |
| 2018 | 3.1 | -15.2 | -10.7 | 0.0 | 20.0 | 60.0 | 14.6 | 9.1 | 41.7 | -18.8 | 2.9 | -18.3 | +81.2% |
| 2017 | 40.0 | 14.3 | 25.0 | -12.0 | 4.5 | -15.2 | -12.8 | -5.9 | -9.4 | -20.7 | 17.4 | 18.5 | +28.0% |
| 2016 | -31.0 | 35.0 | -14.8 | 17.4 | -7.4 | -16.0 | 14.3 | 62.5 | 15.4 | -8.9 | -29.3 | -13.8 | −13.8% |
| 2015 | -28.6 | 30.0 | 4.6 | 61.8 | -26.4 | -16.0 | -4.4 | -15.4 | -36.4 | -14.3 | 16.7 | -17.1 | −58.6% |
| 2014 | 5.1 | -7.7 | -4.7 | 9.9 | -16.0 | -15.5 | 7.0 | 0.7 | -17.0 | -13.4 | -17.3 | -23.1 | −64.5% |
| 2013 | 21.6 | -12.6 | -7.5 | -12.1 | -5.9 | -22.4 | -15.3 | 25.5 | 17.8 | 13.7 | 32.9 | -6.2 | +11.9% |
| 2012 | 37.5 | -4.2 | 16.8 | 8.4 | -15.0 | 18.8 | -30.2 | -7.8 | -25.0 | 4.6 | -3.4 | -10.7 | −26.7% |
| 2011 | -5.0 | -3.5 | -3.6 | 239.6 | 48.3 | 42.3 | -14.5 | -9.2 | -16.9 | 10.2 | -19.6 | 10.6 | +300.0% |
| 2010 | -23.1 | -5.0 | 5.3 | 27.5 | -19.6 | 9.8 | -11.1 | -2.5 | 41.0 | -18.2 | -11.1 | 50.0 | +15.4% |
| 2009 | 0.0 | 66.7 | -16.7 | 40.0 | -5.7 | -6.1 | 41.9 | -20.5 | 14.3 | 30.0 | -26.9 | 36.8 | +188.9% |
| 2008 | 8.7 | 4.0 | 15.4 | -8.3 | -16.4 | 13.0 | -23.1 | -5.0 | -21.1 | -10.0 | -25.9 | -10.0 | −60.9% |
| 2007 | 28.2 | 34.0 | -3.0 | -6.2 | 39.3 | -8.2 | -3.8 | -37.3 | 36.2 | 1.6 | -18.5 | -13.2 | +17.9% |
Buy / hold / sell counts
United States Antimony Corporation produces and sells antimony, zeolite, and precious metals in the United States and Canada. It operates in two segments: Antimony and Zeolite. The company offers antimony trioxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony metal for use in bearings, storage batteries, and ordnance; and antimony trisulfide used as a primer in ammunition. The company also offers coarse and fine zeolite for soil amendment and fertilizer, water filtration, mine underground ventilation, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, and animal nutrition applications, as well as catalysts, petroleum refining, concrete, solar energy and heat exchange, desiccants, pellet binding, horse and kitty litter, floor cleaner, traction control, ammonia removal from mining waste, and carriers for insecticides, pesticides and herbicides. In addition, it recovers unrefined and refined gold and silver. United States Antimony Corporation was founded in 1968 and is headquartered in Dallas, Texas.